Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05400174 · ClinicalTrials.gov registry record · NA

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

A NA study of Parkinson Disease and Orthostatic Hypotension, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05400174 is a NA study of Parkinson Disease and Orthostatic Hypotension that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 60 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05400174, a NA study of Parkinson Disease and Orthostatic Hypotension, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of people with PD have OH, which can cause sudden, temporary symptoms while upright, including lightheadedness, dizziness, and fainting. People with PD and OH can also experience problems thinking that happen only while upright and not while sitting - this can occur without other symptoms, such as feeling dizzy or faint. However, the level of low BP that can affect thinking remains unknown, and no guidelines exist for treating OH when it happens without symptoms. This is significant because OH could be a treatable risk factor for thinking problems in PD, but OH is often not treated if people do not report obvious symptoms. This project's goal is to determine how BP affects brain function in PD. The proposed experiments will measure BP and brain blood flow continuously in real-time using innovative wearable technology. Persons with PD with OH and without OH will undergo repeated cognitive tests while supine (lying down) and while upright. I will study the associations between BP, thinking abilities, and brain blood flow, and will compare groups with and without OH. These findings could be important because if a certain level of BP correlates with thinking abilities, then treating OH in PD may prevent thinking problems, which would improve health-related quality of life and reduce disability and healthcare costs.

Interventions

  • DIAGNOSTIC_TEST Tilt table (upright position)

Study Locations (1)

California

  • University of California San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-12-14
Est. Completion 2026-02-01
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05400174

The ClinicalTrials.gov registry entry for NCT05400174 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Tilt table (upright position) is the first listed.

NCT05400174 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05400174 about?

NCT05400174 is a clinical study titled "Blood Pressure Effects on Cognition and Brain Blood Flow in PD". Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of peopl...

What is the current status of trial NCT05400174?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-12-14. Estimated completion is 2026-02-01.

What conditions does trial NCT05400174 study?

This clinical trial studies the following conditions: Parkinson Disease, Orthostatic Hypotension, Dysautonomia.

What interventions are being tested in trial NCT05400174?

The interventions under investigation include: Tilt table (upright position) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05400174?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05400174 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.